Beroni Group Limited, together with its subsidiaries, develops and sells smoking control products, air purifiers, water filters, and health care products and supplements in China, Australia, the United States, and Japan. It operates through Nicobloc, Fogibloc Air Purifier, Olansi Water Filter, Health Supplements, Cosmetic products, and Viral Diagnostic Kits segments. The company's products include NicoBloc, a smoking cessation/harm reduction product; and Fogibloc, an air purifier system. It also offers cosmetic products, such as V show rejuvenation liquids, hyaluronic acid moisturizing silk masks, and avocado poly-peptide intensive treatment silk masks. In addition, the company provides SARS-CoV-2 IgG/IgM antibody detection kit, as well as sells CII-ArboViroPlex rRT-PCR assay, a diagnostic kit used to detect viruses such as Zika, Dengue, Chikungunya, and West Nile. Further, it engages in the research and development of new drugs and clinical trial; gene detection and diagnosis, as well as sale of cell therapies for cancer and anti-aging treatments; developing new anti-cancer drugs; detection and diagnosis of infectious diseases; and e-commerce platform for pharmaceutical and healthcare products. Additionally, the company sells stem cell cosmetic products. The company was founded in 2014 and is headquartered in Sydney, Australia.